|1.||Nuradin, Nebil: 1 article (06/2015)|
|2.||Lyons, Erica W: 1 article (06/2015)|
|3.||Sahoo, Daisy: 1 article (06/2015)|
|4.||Li, Xiang-An: 1 article (06/2015)|
|5.||Fulp, Brian: 1 article (06/2015)|
|6.||Zhu, Xuewei: 1 article (06/2015)|
|7.||Zabalawi, Manal: 1 article (06/2015)|
|8.||Thomas, Michael J: 1 article (06/2015)|
|9.||Gerelus, Mark: 1 article (06/2015)|
|10.||Pollard, Ricquita D: 1 article (06/2015)|
|1.||Septic Shock (Toxic Shock Syndrome)
08/01/2013 - "As expected, HDL cholesteryl ester uptake was impaired in Ldlr (-/-) Scarb1 (I179N) mice compared to Ldlr (-/-) control mice, with a net effect of increased small and very small LDL cholesterol in Ldlr (-/-) Scarb1 (I179N) mice being the most probable cause of the observed increased atherosclerosis. "
06/19/2015 - "Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake."
02/01/2001 - "Cholesteryl ester transfer protein (CETP) plays a controversial role in atherogenesis by contributing to the net transfer of high density lipoprotein (HDL) cholesteryl ester (CE) to the liver via apolipoprotein-B-containing lipoproteins (apoB-LP). "
|3.||Lecithin Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency)
03/01/1988 - "The normalization of the HDL cholesteryl ester percentage induced by incubation with purified normal LCAT also was accompanied by an increase in the size of the original fish eye disease HDL particles, which had a mean mass of 115 kd, to HDL particle populations with mean particle masses ranging from 130-220 kd, depending on the concentration of purified LCAT in the incubate. "
01/01/1987 - "The observed normalization of both HDL cholesteryl ester percentage and particle size by lipoprotein depleted pig plasma which contains virtually no cholesteryl ester transfer activity indicates that the latter is not a requisite for esterification of the free cholesterol of fish eye disease HDL."
|4.||Type 2 Diabetes Mellitus (MODY)
05/18/2012 - "Furthermore, in the isolated HDL; HDL-phospholipid and HDL-cholesterol ester content were higher in HNF1A-MODY, than in Type 2 diabetes (1.59 vs. 1.33 mmol/L, p = 0.04 and 1.10 vs. 0.83 mmol/L, p = 0.019, respectively), but were similar to controls (1.59 vs. 1.45 mmol/L, p = 0.35 and 1.10 vs. 1.21 mmol/L, p = 0.19, respectively). "
09/01/1998 - "Plasma cholesteryl ester transfer appears to be a determinant of HDL cholesteryl ester, but other factors are likely to contribute to lower HDL cholesteryl ester levels in NIDDM."
09/01/1998 - "HDL cholesteryl ester was negatively related to CET (P= 0.017), HL activity (P = 0.033) and NIDDM (P = 0.047) and positively to LCAT activity levels (P = 0.034, multiple r = 0.68). "
|5.||Peripheral Vascular Diseases (Peripheral Vascular Disease)
10/16/1989 - "In vitro net mass transfer of HDL cholesteryl ester to apolipoprotein (Apo) B-containing lipoproteins (HDL-CET) was found to be nearly twofold higher in plasma from 35 male patients with peripheral vascular disease compared to the values of 27 age- and sex-matched healthy controls (P less than 0.001). "
|1.||Scavenger Receptors (Scavenger Receptor)
|2.||high density lipoprotein receptors
|5.||Apolipoproteins B (ApoB)
|6.||Cholesterol Ester Transfer Proteins
|7.||Apolipoprotein A-I (Apolipoprotein A1)
|9.||Bone Morphogenetic Protein 1
|10.||Glucocorticoid Receptors (Glucocorticoid Receptor)